Agenus

Agenus

Employees:
260
Market Cap:
$371.22 million
Revenue:
$22.79 million
5 Year Trend:
52.2%
Net Income:
$-122.1 million
NASDAQ:
AGEN

Agenus is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the power of the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants that can be used with a range of vaccines. Wikipedia

Agenus
Employees:
260
Market Cap:
$371.22 million
Revenue:
$22.79 million
5 Year Trend:
52.2%
Net Income:
$-122.1 million
NASDAQ:
AGEN

Agenus is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the power of the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants that can be used with a range of vaccines. Wikipedia